— Harley-Davidson shares gained 5.2% after a Citigroup analyst initiated coverage of the motorcycle builder with a buy rating, citing optimism around the company's recent leadership changes. "The new CEO, Jochen Zeitz's track record and marketing acumen as CEO of PUMA sporting goods augurs well," the analyst said.— An analyst at Baird hiked his price target on the video-conferencing giant to $300 per share from $230 per share. The new price target implies a 14.
— Shares of the biopharmaceutical company jumped more than 8% on the back of positive phase 3 trial results for Trodelvy, a drug aimed at treating patients with metastatic triple-negative breast cancer. The study, Immunomedics said, confirms the drug "has the potential to change the standard management of mTNBC."— Globus Medical shares fell 6.3% after Piper Sandler downgraded them to neutral from overweight.
CBOE Volatility Index (.VIX:Exchange) is up today. Meesa thinks this rally smells fishy.
What a joke of a market. It’s clearly 1999 all over again thanks to the slimy FED.
$TSLA 🔥
Bull trap.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »
Source: BusinessInsider - 🏆 729. / 51 Read more »